News For Drugs Generic


Prime Therapeutics keeps high drug cost trends at bay: annual trend reports released - BioSpace

Prime Therapeutics keeps high drug cost trends at bay: annual trend reports released  BioSpace

EAGAN, Minn., /PRNewswire/ -- Clients of Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) with more than 28 million members ...

Google 3/19/2019 6:50:18 PM

Nabriva Therapeutics: 2 Novel Antibiotics, 2 Sets Of Problems - Seeking Alpha

Nabriva Therapeutics: 2 Novel Antibiotics, 2 Sets Of Problems  Seeking Alpha

Nabriva has PDUFAs for two antibiotics, lefamulin and Contepo. Trial results have generally been good to superlative. However, given the state of the antibiotic.

Google 3/19/2019 6:17:49 PM

Worldwide Generic Drugs Market Report 2018, Forecast to 2025 - Redfield Report

Worldwide Generic Drugs Market Report 2018, Forecast to 2025  Redfield Report

Latest Report of Title: “Global Generic Drugs Market Insights, Forecast to 2025”. Generic Drugs Market Report 2019 studies the market status and standpoint of ...

Google 3/19/2019 6:11:00 PM

Worldwide Inhalation & Nasal Spray Generic Drugs Market Report 2018, Forecast to 2025 - The Beaumont Daily

Worldwide Inhalation & Nasal Spray Generic Drugs Market Report 2018, Forecast to 2025  The Beaumont Daily

Latest Report of Title: “Global Inhalation & Nasal Spray Generic Drugs Market Insights, Forecast to 2025”. Inhalation & Nasal Spray Generic Drugs Market Report ...

Google 3/19/2019 6:02:47 PM

Supernus Pharmaceuticals Does Not Impress In ADHD - Seeking Alpha

Supernus Pharmaceuticals Does Not Impress In ADHD  Seeking Alpha

Supernus was not able to differentiate its drug in ADHD with generic competition. Its existing product line probably does not justify its current market cap. De.

Google 3/19/2019 5:48:37 PM

Urovant Bladder Drug Hits Test Goals But Can't Outpace Generic Rival - Xconomy

Urovant Bladder Drug Hits Test Goals But Can't Outpace Generic Rival  Xconomy

Urovant Sciences says its experimental drug for overactive bladder could offer advantages compared to an FDA-approved treatment marketed by Astellas.

Google 3/19/2019 5:28:13 PM

Recon: FDA Places Partial Hold on Trials for AbbVie's Venclexta - Regulatory Focus

Recon: FDA Places Partial Hold on Trials for AbbVie's Venclexta  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. FDA puts partial hold on clinical trials of AbbVie's ...

Google 3/19/2019 4:54:17 PM

Active Pharmaceutical Ingredients Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 - GlobeNewswire

Active Pharmaceutical Ingredients Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024  GlobeNewswire

Dublin, March 19, 2019 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and ...

Google 3/19/2019 4:42:00 PM

 1 2 3 4 5  ...